Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1037158rdf:typepubmed:Citationlld:pubmed
pubmed-article:1037158lifeskim:mentionsumls-concept:C0684336lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C0018613lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C0032176lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:1037158lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:1037158pubmed:issue3lld:pubmed
pubmed-article:1037158pubmed:dateCreated1977-4-15lld:pubmed
pubmed-article:1037158pubmed:abstractTextADP-induced aggregation of washed human platelets is inhibited by the hashish components delta1-tetrahydrocannabinol (THC) and cannabidiol (CBD). The inhibition is counteracted by added ADP. When the cannabinoids are present at concentrations higher than 10(-5)M, the platelets aggregate non-reversibly, independently of an added inducer, apparently due to lysis and release of endogenous inducers. THC is clearly more potent than CBD in exhibiting the biphasic effect. Collagen- and thrombin-induced aggregation of washed platelets are hardly affected by the cannabinoids. THC and CBD also curtail ADP-induced reversible aggregation in platelet-rich plasma, while serotonin release and irreversible aggregation, caused by either ADP, collagen or thrombin, are not affected by the cannabinoids in platelet-rich plasma. The data point to associated sites for ADP and the cannabinoids on the platelet membrane.lld:pubmed
pubmed-article:1037158pubmed:languageenglld:pubmed
pubmed-article:1037158pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1037158pubmed:citationSubsetIMlld:pubmed
pubmed-article:1037158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1037158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1037158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1037158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1037158pubmed:statusMEDLINElld:pubmed
pubmed-article:1037158pubmed:monthDeclld:pubmed
pubmed-article:1037158pubmed:issn0340-6245lld:pubmed
pubmed-article:1037158pubmed:authorpubmed-author:LevyRRlld:pubmed
pubmed-article:1037158pubmed:authorpubmed-author:LivneAAlld:pubmed
pubmed-article:1037158pubmed:authorpubmed-author:NathanIIlld:pubmed
pubmed-article:1037158pubmed:authorpubmed-author:SchurrAAlld:pubmed
pubmed-article:1037158pubmed:authorpubmed-author:DvilanskiAAlld:pubmed
pubmed-article:1037158pubmed:issnTypePrintlld:pubmed
pubmed-article:1037158pubmed:day31lld:pubmed
pubmed-article:1037158pubmed:volume36lld:pubmed
pubmed-article:1037158pubmed:ownerNLMlld:pubmed
pubmed-article:1037158pubmed:authorsCompleteYlld:pubmed
pubmed-article:1037158pubmed:pagination634-40lld:pubmed
pubmed-article:1037158pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1037158pubmed:meshHeadingpubmed-meshheading:1037158-...lld:pubmed
pubmed-article:1037158pubmed:meshHeadingpubmed-meshheading:1037158-...lld:pubmed
pubmed-article:1037158pubmed:meshHeadingpubmed-meshheading:1037158-...lld:pubmed
pubmed-article:1037158pubmed:meshHeadingpubmed-meshheading:1037158-...lld:pubmed
pubmed-article:1037158pubmed:meshHeadingpubmed-meshheading:1037158-...lld:pubmed
pubmed-article:1037158pubmed:meshHeadingpubmed-meshheading:1037158-...lld:pubmed
pubmed-article:1037158pubmed:year1976lld:pubmed
pubmed-article:1037158pubmed:articleTitleImpairment of ADP-induced platelet aggregation by hashish components.lld:pubmed
pubmed-article:1037158pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1037158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1037158lld:pubmed